Status:
UNKNOWN
Adaptive Planning in Bladder Cancer
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Collaborating Sponsors:
Institute of Cancer Research, United Kingdom
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
To demonstrate that radiotherapy treatments for bladder cancer can be delivered with greater accuracy using a new planning method and that this method can be used simply and effectively by those deliv...
Detailed Description
This study integrates a novel adaptive planning methodology, Adaptive-Planning Organ LOcalisation (A-POLO), with optimised margins and cone beam CT technology for improving the accuracy of radiotherap...
Eligibility Criteria
Inclusion
- Age \> 18
- Histologically confirmed invasive carcinoma of the bladder
- Patient planned to receive hypofractionated radiotherapy to the bladder.
- No previous pelvic radiotherapy
- Written informed consent given according to ICH/GCP and national/local regulations.
Exclusion
- Urinary catheter in situ: the presence of a urinary catheter degrades cone beam image quality and thus images would not be evaluable. Patients with a urinary catheter would not be expected to show variation in bladder filling.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT01000129
Start Date
January 1 2009
End Date
December 1 2010
Last Update
October 22 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Marsden NHS Foundation Trust
Sutton, Surrey, United Kingdom, SM2 5PT